US Stocks
/
Skye Bioscience, Inc. Share Price

Skye Bioscience, Inc. Share Price

NASDAQ: SKYE | Micro Cap
$1.67
-$0.06 (-3.19%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Skye Bioscience, Inc. Stock Performance

Open
$1.68
Prev. Close
$1.73
Circuit Range
N/A
Day Range
$1.63 - $1.68
Year Range
$0.28 - $2.13
Volume
4,488
Average Traded
$1.66

Skye Bioscience, Inc. Share Price Today

As of 9 October 2026, Skye Bioscience, Inc.'s share price is $1.67. The stock opened at $1.68, compared to its previous close of $1.73. During today's trading session, Skye Bioscience, Inc.'s share price traded between $1.63 and $1.68, with an average price of $1.65. Over the past 52 weeks, the stock has recorded a high of $2.13 and a low of $0.28. In terms of performance, Skye Bioscience, Inc.'s share price has risen by 87.85% over the last six months and is up 7.05% on a year-on-year basis.

Skye Bioscience, Inc. Share Price Chart

$1.63$1.68
L
Show Current Price
H

Skye Bioscience, Inc. Stock Fundamentals & Key Indicators

Market Cap
$66.24M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-11.40
Revenue (TTM)
$0.00
Return On Equity (TTM)
10153.20%
Profit Margin
N/A
Debt to Equity
-0.29
Quarterly Earnings Growth YoY
15.37%

Skye Bioscience, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$12.75-$14.44-$12.51-$10.79
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-13.25%13.37%13.75%

Skye Bioscience, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$26.57-$55.92
Net Profit MarginN/AN/A
Income ChangeN/A-110.46%

About Skye Bioscience, Inc.

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Skye Bioscience, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.56
$1.67
+1.83%
Sep 2026
$1.78
$1.64
-18.37%
Aug 2026
$0.57
$2.01
+242.25%
Jul 2026
$0.68
$0.59
-12.52%
Jun 2026
$0.79
$0.67
-13.42%
May 2026
$0.79
$0.78
-12.82%
Apr 2026
$0.68
$0.89
+47.92%
Mar 2026
$0.77
$0.60
-19.11%
Feb 2026
$0.92
$0.74
-26.44%
Jan 2026
$0.74
$1.01
+35.75%
Dec 2025
$1.25
$0.74
-43.85%
Nov 2025
$1.53
$1.32
-15.06%

SKYE Share Price FAQs

What is Skye Bioscience, Inc. share price today?

chevron-up
Skye Bioscience, Inc. share price today is $1.67 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Skye Bioscience, Inc. stock?

chevron-up
The 52 week high of Skye Bioscience, Inc. stock is $2.13, while the 52 week low is $0.28 as of 9 Oct '26.

What is SKYE's market capitalisation today?

chevron-up
SKYE market capitalisation is $66.24M as of October 9, 2026, at 6:21 am IST.

What is SKYE's net income for the last quarter?

chevron-up
SKYE's net income for the last quarter is -10.79B USD.

What is the 5 year returns of SKYE?

chevron-up
The 5 year returns of SKYE is -87.08% as on 9 Oct '26.

What is the high & low stock price of SKYE today?

chevron-up
SKYE stock price hit a high of $1.68 and low of $1.63 as of 9 Oct '26.

Can I buy SKYE shares in India?

chevron-up
Yes. You can buy SKYE in India by opening an international trading account.